Year archive

BioInvent International — 2015 filings

All 51 regulatory filings released by BioInvent International (BINV) in 2015, sourced directly from the official regulator.

51 Filings

2015 Period

2015 filings (51)

Filing	Released	Lang
BioInvent utsett av globalt läkemedelsbolag till leverantör av produktionstjänster. Intäkterna väntas uppgå till ca 25 miljoner kronor Regulatory Filings	2015-12-17	Swedish
BioInvent selected for manufacturing services by global pharmaceutical company; expects to generate about SEK 25 million in revenue Regulatory Filings	2015-12-17	English
BioInvent lämnar uppdatering om bolagets kliniska och prekliniska läkemedelsprojekt Regulatory Filings	2015-12-16	Swedish
BioInvent update on clinical and preclinical drug programs Regulatory Filings	2015-12-16	English
BioInvent inlicensierar banbrytande teknologi för utveckling av mer effektiva cancerbehandlingar Regulatory Filings	2015-12-10	Swedish
BioInvent in-licenses cutting edge technology to pave the way for more efficacious cancer treatments Regulatory Filings	2015-12-10	English
Interim / Quarterly Report 2015 Interim / Quarterly Report 9M 2015	2015-10-22	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report 9M 2015	2015-10-22	English
BioInvent deltar i Ladenburg Thalmann 2015 Healthcare Conference Regulatory Filings	2015-09-28	Swedish
BioInvent to Participate in Ladenburg Thalmann 2015 Healthcare Conference Regulatory Filings	2015-09-28	English
BioInvent and the University of Pennsylvania enhance planned clinical study with BI-505 Earnings Release FY 2015	2015-09-21	English
BioInvent och University of Pennsylvania utökar den planerade kliniska studien med BI-505 Regulatory Filings	2015-09-21	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report H2 2015	2015-07-22	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report H2 2015	2015-07-22	English
BioInvent utvidgar kommande fas I/IIa-studie av TB-403 Regulatory Filings	2015-07-08	Swedish
Framsteg i BioInvents samarbete med ledande amerikanskt bioteknikföretag Regulatory Filings	2015-06-17	Swedish
BioInvent progresses collaboration with leading U.S. biotechnology company M&A Activity	2015-06-17	English
Managements aktieinnehav efter genomförd företrädesemission Board/Management Information	2015-06-15	Swedish
Management's shareholding after completion of the rights issue Director's Dealing	2015-06-15	English
BioInvent utökar sitt forskningssamarbete med University of Southampton Regulatory Filings	2015-06-01	Swedish
BioInvent enters into third research collaboration with University of Southampton Regulatory Filings	2015-06-01	English
Change in the number of shares and votes in BioInvent International AB (publ) Declaration of Voting Results & Voting Rights Announcements	2015-05-29	English
Ändring av antalet aktier och röster i BioInvent International AB (publ) Share Issue/Capital Change	2015-05-29	Swedish
BioInvent’s rights issue oversubscribed Share Issue/Capital Change	2015-05-18	English
BioInvents företrädesemission övertecknad Capital/Financing Update	2015-05-18	Swedish
BioInvent offentliggör prospekt för företrädesemissionen Report Publication Announcement	2015-04-24	Swedish
BioInvent publishes prospectus for the rights issue Share Issue/Capital Change	2015-04-24	English
Årsstämma i BioInvent International AB (publ) AGM Information	2015-04-22	Swedish
Annual General Meeting in BioInvent International AB (publ) AGM Information	2015-04-22	English
Interim / Quarterly Report 2015 Interim / Quarterly Report Q1 2015	2015-04-22	Swedish
Interim / Quarterly Report 2015 Interim / Quarterly Report Q1 2015	2015-04-22	English
The Board of Directors of BioInvent resolves on terms for right issue Capital/Financing Update	2015-04-17	English
Styrelsen i BioInvent fastställer villkor för företrädes-emissionen Capital/Financing Update	2015-04-17	Swedish
Cancer Cell publicerar data som visar att BioInvents BI-1206 har potential att motverka resistens mot antikroppsläkemedel vid behandling av cancer Regulatory Filings	2015-04-14	Swedish
Cancer Cell publishes data highlighting the potential of BioInvent’s BI-1206 to help overcome antibody drug resistance in cancer therapy Regulatory Filings	2015-04-14	English
BioInvent and CRT expand collaboration with University of Southampton scientists to develop new immunotherapy treatments for cancer Regulatory Filings	2015-03-30	English
BioInvent och CRT utökar samarbete med forskare vid University of Southampton för att utveckla nya immunterapeutiska cancerläkemedel Regulatory Filings	2015-03-30	Swedish
Annual Report 2014 Annual Report FY 2014	2015-03-25	Swedish
Annual Report 2014 Annual Report FY 2014	2015-03-25	English
Notice of Annual General Meeting in BioInvent International AB AGM Information	2015-03-23	English
Kallelse till årsstämma i BioInvent International AB AGM Information	2015-03-23	Swedish
BioInvent reviderar klinisk strategi för BI-505; planerar fas IIa-studie i USA på multipelt myelom-patienter efter stamcellstransplantation Regulatory Filings	2015-03-19	Swedish
BioInvent confirms clinical strategy for BI-505 and plans to conduct phase IIa trial in multiple myeloma post-stem cell transplant patients in the US Investor Presentation	2015-03-19	English
BioInvent planerar att starta klinisk utveckling av TB-403 för behandling av pediatrisk cancer tillsammans med ThromboGenics Regulatory Filings	2015-03-17	Swedish
BioInvent announces plan to initiate clinical development of TB-403 in pediatric cancer together with ThromboGenics Regulatory Filings	2015-03-17	English
Interim / Quarterly Report 2014 Interim / Quarterly Report Q4 2014	2015-02-18	Swedish
Audit Report / Information 2014 Audit Report / Information FY 2014	2015-02-18	English
BioInvent appoints head of clinical development Board/Management Information	2015-01-22	English
BioInvent utser chef för klinisk utveckling Board/Management Information	2015-01-22	Swedish
BioInvents antikropp BI-1206 avancerar till fas l/ll-studie med full finansiering av Cancer Research UK, CRT och LLR Regulatory Filings	2015-01-20	Swedish
BioInvent’s BI-1206 antibody to enter collaborative Phase l/ll trial funded and conducted by Cancer Research UK, CRT and LLR Regulatory Filings	2015-01-20	English

Filings by year

2026 11 filings
2025 39 filings
2024 23 filings
2023 29 filings
2022 31 filings
2021 49 filings
2020 55 filings
2019 45 filings
2018 43 filings
2017 28 filings
2016 60 filings
2015 51 filings
2014 40 filings
2013 54 filings
2012 36 filings
2011 23 filings
2010 24 filings
2009 19 filings
2008 12 filings
2007 5 filings